SCLC, EXTENSIVE STAGE
Clinical trials for SCLC, EXTENSIVE STAGE explained in plain language.
Never miss a new study
Get alerted when new SCLC, EXTENSIVE STAGE trials appear
Sign up with your email to follow new studies for SCLC, EXTENSIVE STAGE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New triple therapy shows promise for aggressive lung cancer
Disease control CompletedThis study tested a combination of two drugs (durvalumab and anlotinib) plus standard chemotherapy as a first treatment for people with extensive-stage small-cell lung cancer, a fast-growing cancer. 34 adults took part. The goal was to see if the combo helps delay cancer growth o…
Matched conditions: SCLC, EXTENSIVE STAGE
Phase: PHASE2 • Sponsor: Henan Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Hope for frail lung cancer patients: immunotherapy combo shows promise
Disease control CompletedThis study tested whether adding the immunotherapy drug atezolizumab to standard chemotherapy can help people with advanced small cell lung cancer who are in poor health. The trial included 70 patients with extensive-stage disease and a low performance status (ECOG 2). Researcher…
Matched conditions: SCLC, EXTENSIVE STAGE
Phase: PHASE2 • Sponsor: AIO-Studien-gGmbH • Aim: Disease control
Last updated Jun 26, 2026 15:06 UTC